Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag

Molecular Endocrinology

Volumn 27, Issue 8, 2013, Pages 1267-1282

  Chepurny, Oleg G ^a   Bertinetti, Daniela ^a   Diskar, Mandy ^b   Leech, Colin A ^a   Afshari, Parisa ^a   Tsalkova, Tamara ^c   Cheng, Xiaodong ^c   Schwede, Frank ^d   Genieser, Hans G ^d   Herberg, Friedrich W ^b   Holz, George G ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY OF KASSEL   (Germany)

^c University of Texas Medical Branch School of Medicine   (United States)

^d BIOLOG Life Science Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DERIVATIVE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; PROGLUCAGON; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ENTEROENDOCRINE CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; L CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS;

ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENTEROENDOCRINE CELLS; ETHANOLAMINES; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEK293 CELLS; HUMANS; INCRETINS; L CELLS (CELL LINE); MICE; PROGLUCAGON; PROMOTER REGIONS, GENETIC; PYRIMIDINES; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 84880851406     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1029     Document Type: Article

References (72)

1. Fredriksson R, Höglund PJ, Gloriam DE, Lagerström MC, Schiöth HB. Seven evolutionarily conserved human rhodopsin G proteincoupled receptors lacking close relatives. FEBS Lett. 2003;554: 381-388
2. Chu ZL, Carroll C, Alfonso J, et al. A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology. 2008;149:2038-2047
3. Jones RM, Leonard JN, Buzard DJ, Lehmann J. GPR119 agonists for the treatment of type 2 diabetes. Expert Opin Ther Pat. 2009; 19:1339-1359
4. Hansen KB, Rosenkilde MM, Knop FK, et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab. 2011;96:E1409-E1417
5. Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006; 3:167-175
6. Shah U, Kowalski TJ. GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. Vitam Horm. 2010;84:415-448
7. Soga T, Ohishi T, Matsui T, et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein- coupled receptor. Biochem Biophys Res Commun. 2005;326: 744-751
8. Chu ZL, Jones RM, He H, et al. A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose- dependent insulin release. Endocrinology. 2007;148:2601-2609
9. Overton HA, Fyfe MC, Reynet C. GPR119, a novel G proteincoupled receptor target for the treatment of type 2 diabetes and obesity. Br J Pharmacol. 2008;153(Suppl 1):S76-S81
10. Ahrén B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov. 2009;8:369-385
11. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem. 1986;261:11880-11889
12. Drucker DJ, Brubaker PL. Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine. Proc Natl Acad Sci USA. 1989;86:3953-3957
13. Drucker DJ, Jin T, Asa SL, Young TA, Brubaker PL. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol. 1994;8:1646-1655
14. Smit MJ, Vischer HF, Bakker RA, et al. Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annu Rev Pharmacol Toxicol. 2007;47:53-87
15. Chalmers DT, Behan D. The use of constitutively active GPCRs in drug discovery and functional genomics. Nat Rev Drug Discov. 2002;1:599-608
16. Santerre RF, Cook RA, Crisel RM, et al. Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic [1] cells. Proc Natl Acad Sci USA. 1981;78:4339-4343
17. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin- secreting cell lines. Endocrinology. 1992;130:167-178
18. Gromada J, Rorsman P, Dissing S, Wulff BS. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release. FEBS Lett. 1995;373:182-186
19. Lü F, Jin T, Drucker DJ. Proglucagon gene expression is induced by gastrin-releasing peptide in a mouse enteroendocrine cell line. Endocrinology. 1996;137:3710-3716
20. Chepurny OG, Holz GG. A novel cyclic adenosine monophosphate responsive luciferase reporter incorporating a nonpalindromic cyclic adenosine monophosphate response element provides optimal performance for use in G protein coupled receptor drug discovery efforts. J Biomol Screen. 2007;12:740-746
21. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol. 1998;18:967-977
22. Berlot CH. A highly effective dominant negative s construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways. J Biol Chem. 2002;277: 21080-21085
23. Rogers KV, Goldman PS, Frizzell RA, McKnight GS. Regulation of Cl transport in T84 cell clones expressing a mutant regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA. 1990;87:8975-8979
24. Uhler MD, Carmichael DF, Lee DC, Chrivia JC, Krebs EG, McKnight GS. Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase. Proc Natl Acad Sci USA. 1986;83:1300-1304
25. Herbst KJ, Coltharp C, Amzel LM, Zhang J. Direct activation of Epac by sulfonylurea is isoform selective. Chem Biol. 2011;18:243-251
26. Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000;2:805-811
27. Li Y, Asuri S, Rebhun JF, Castro AF, Paranavitana NC, Quilliam LA. The RAP1 guanine nucleotide exchange factor Epac2 couples cyclic AMP and Ras signals at the plasma membrane. J Biol Chem. 2006;281:2506-2514
28. Chepurny OG, Leech CA, Kelley GG, et al. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2-O-Me-cAMP-AM. J Biol Chem. 2009;284: 10728-10736
29. Tsalkova T, Mei FC, Li S, et al. Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc Natl Acad Sci USA. 2012;109:18613-18618
30. Loening AM, Fenn TD, Wu AM, Gambhir SS. Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel. 2006;19:391-400
31. Prinz A, Diskar M, Erlbruch A, Herberg FW. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET). Cell Signal. 2006; 18:1616-1625
32. Ponsioen B, Zhao J, Riedl J, et al. Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep. 2004;5:1176-1180
33. Olsen SR, Uhler MD. Affinity purification of the C α and Cβ isoforms of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem.1989;264:18662-18666
34. Bertinetti D, Schweinsberg S, Hanke SE, et al. Chemical tools selectively target components of the PKA system. BMC Chem Biol. 2009;9:3
35. Cook PF, Neville ME Jr, Vrana KE, Hartl FT, Roskoski R Jr. Adenosine cyclic 3, 5-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit. Biochemistry. 1982;21:5794-5799
36. Jin T, Drucker DJ. Activation of proglucagon gene transcription through a novel promoter element by the caudal-related homeodomain protein cdx-2/3. Mol Cell Biol. 1996;16:19-28
37. Chijiwa T, Mishima A, Hagiwara M, et al. Inhibition of foskolininduced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990;265:5267-5272
38. Yoshida S, Ohishi T, Matsui T, Shibasaki M. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose- stimulated insulin secretion. Biochem Biophys Res Commun. 2010;400:437-441
39. Lotfi S, Li Z, Sun J, et al. Role of the exchange protein directly activated by cyclic adenosine 5-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells. Endocrinology. 2006;147:3727-3736
40. Islam D, Zhang N, Wang P, et al. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic - and intestinal L-cell lines. Am J Physiol Endocrinol Metab. 2009;296:E174-E181
41. Wang P, Wang Q, Sun J, et al. POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP. J Biol Chem. 2009;284: 26456-26465
42. Enserink JM, Christensen AE, de Rooij J, et al. A novel Epacspecific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol. 2002;4:901-906
43. Holz GG, Chepurny OG, Schwede F. Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal. 2008;20:10-20
44. Jin T. Mechanisms underlying proglucagon gene expression. J Endocrinol. 2008;198:17-28
45. Yu Z, Jin T. New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP- 1). Cell Signal. 2010;22:1-8
46. Vliem MJ, Ponsioen B, Schwede F, et al.8-pCPT-2-O-Me-cAMPAM: an improved Epac-selective cAMP analogue. Chembiochem. 2008;9:2052-2054
47. Gjertsen BT, Mellgren G, Otten A, et al. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1[1] action. J Biol Chem. 1995;270:20599-20607
48. Jessen HJ, Schulz T, Balzarini J, Meier C. Bioreversible protection of nucleoside diphosphates. Angew Chem Int Ed Engl. 2008;47: 8719-8722
49. Holst B, Nygaard R, Valentin-Hansen L, et al. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seventransmembrane receptors. J Biol Chem. 2010;285:3973-3985
50. Valentin-Hansen L, Holst B, Frimurer TM, Schwartz TW. PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation. J Biol Chem. 2012;287:43516-43526
51. Lan H, Vassileva G, Corona A, et al. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol. 2009;201:219-223
52. Hansen HS, Rosenkilde MM, Holst JJ, Schwartz TW. GPR119 as a fat sensor. Trends Pharmacol Sci. 2012;33:374-381
53. Lester LB, Langeberg LK, Scott JD. Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA. 1997;94:14942-14947
54. Fraser ID, Tavalin SJ, Lester LB,. A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J. 1998;17:2261-2272
55. Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes. 2009;58: 1058-1066
56. Lan H, Lin HV, Wang CF. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. Br J Pharmacol. 2012;165:2799-2807
57. Rozengurt N, Wu SV, Chen MC, Huang C, Sternini C, Rozengurt E. Colocalization of the -subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol. 2006;291:G792-G802
58. Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide- 1. Proc Natl Acad Sci USA. 2007;104:15069-15074
59. Kokrashvili Z, Mosinger B, Margolskee RF. Taste signaling elements expressed in gut enteroendocine cells regulate nutrient-responsive secretion of gut hormones. Am J Clin Nutr. 2009;90: 822S-825S.
60. Li Y, Kokrashvili Z, Mosinger B, Margolskee RF. Gustducin couples fatty acid receptors to GLP-1 release in colon. Am J Physiol Endocrinol Metab. 2013;304:E651-E660
61. Herberg FW, Dostmann WR, Zorn M, Davis SJ, Taylor SS. Crosstalk between domains in the regulatory subunit of cAMP-dependent protein kinase: influence of amino terminus on cAMP binding and holoenzyme formation. Biochemistry. 1994;33:7485-7494
62. Herberg FW, Taylor SS, Dostmann WR. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase. Biochemistry. 1996;35:2934-2942
63. Herberg FW, Doyle ML, Cox S, Taylor SS. Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase. Biochemistry. 1999;38:6352-6360
64. Gibson RM, Ji-Buechler Y, Taylor SS. Interaction of the regulatory and catalytic subunits of cAMP-dependent protein kinase. Electrostatic sites on the type I regulatory subunit. J Biol Chem. 1997; 272:16343-16350
65. Ringheim GE, Taylor SS. Dissecting the domain structure of the regulatory subunit of cAMP-dependent protein kinase I and elucidating the role of MgATP. J Biol Chem. 1990;265:4800-4808
66. Diskar M, Zenn H-M, Kaupisch A, et al. Regulation of cAMPdependent protein kinases: the human protein kinase X (PrKX) reveals the role of the catalytic subunit H-I loop. J Biol Chem. 2010;285:35910-35918
67. Moll D, Prinz A, Brendel CM, et al. Biochemical characterization and cellular imaging of a novel, membrane permeable fluorescent cAMP analog. BMC Biochem. 2008;9:18
68. Cadd GG, Uhler MD, McKnight GS. Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides. J Biol Chem. 1990;265:19502-19506
69. Diskar M, Zenn HM, Kaupisch A, Prinz A, Herberg FW. Molecular basis for isoform-specific autoregulation of protein kinase A. Cell Signal. 2007;19:2024-2034
70. Zhang P, Smith-Nguyen EV, Keshwani MM, Deal MS, Kornev AP, Taylor SS. Structure and allostery of the PKA RII[1] tetrameric holoenzyme. Science. 2012;335:712-716
71. Vetter MM, Zenn HM, Méndez E, van den Boom H, Herberg FW, Skålhegg BS. The testis-specific C2 subunit of PKA is kinetically indistinguishable from the common C1 subunit of PKA. BMC Biochem. 2011;12:40
72. Dzhura I, Chepurny OG, Kelley GG, et al. Epac2-dependent mobilization of intracellular Ca2+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-knockout mice. J Physiol. 2010;588:4871-4889.